Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:07:17 EST Wed 17 Dec 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:TIVC - TIVIC HEALTH SYSTEMS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TIVC - Q0.11.83·4.890.12.0011.4201252.01  2.0711  2.0015.64  1.4716:00:01Dec 1115 min RT 2¢

Recent Trades - Last 10 of 125
Time ETExPriceChangeVolume
16:00:01Q2.030.0210
16:00:01Q2.030.0210
16:00:01Q2.030.0210
16:00:01Q2.030.029
16:00:01Q2.030.0211
16:00:01Q2.030.025
16:00:01Q2.030.025
16:00:01Q2.030.025
15:59:52Q2.01 1
15:59:52Q2.030.0210

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-12-11 09:46U:TIVCNews ReleaseTivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package
2025-11-18 08:30U:TIVCNews ReleaseTivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome
2025-11-14 16:30U:TIVCNews ReleaseTivic Reports Third Quarter 2025 Financial Results
2025-11-13 08:30U:TIVCNews ReleaseTivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)
2025-11-10 09:00U:TIVCNews ReleaseTivic Expands Intellectual Property Portfolio
2025-11-06 09:30U:TIVCNews ReleaseTivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast
2025-10-22 14:00U:TIVCNews ReleaseTivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23
2025-09-22 08:30U:TIVCNews ReleaseTivic Health CEO Jennifer Ernst to Present at Emerging Growth's September Virtual Conference
2025-09-10 08:30U:TIVCNews ReleaseTivic Completes Verification of Entolimod(TM) Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing
2025-08-20 08:30U:TIVCNews ReleaseTivic Receives Two Investigational New Drug Applications for Entolimod(TM) for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers
2025-08-15 08:30U:TIVCNews ReleaseTivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025
2025-08-14 16:00U:TIVCNews ReleaseTivic Reports Second Quarter 2025 Financial Results
2025-08-07 08:30U:TIVCNews ReleaseTivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast
2025-07-08 08:30U:TIVCNews ReleaseTivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO
2025-06-25 08:30U:TIVCNews ReleaseTivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device
2025-06-24 08:30U:TIVCNews ReleaseTivic Health Announces 2025 Annual Meeting of Stockholders
2025-05-15 16:05U:TIVCNews ReleaseTivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation
2025-05-14 08:30U:TIVCNews ReleaseTivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission
2025-05-13 08:30U:TIVCNews ReleaseTivic Expands VNS Intellectual Property Portfolio
2025-05-09 08:30U:TIVCNews ReleaseTivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast